Position in AZN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,562,524
+$397,246 QoQ
Shares Held
13,514
+23.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#481
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MMBG INVESTMENT ADVISORS CO. holds $24,468,004 across 8 Drug Manufacturers - General names. AZN ranks #4 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,070 | $10,878,831 | |
| 2 | ABBV |
AbbVie Inc.
|
17,115 | $4,306,818 | |
| 3 | MRK |
Merck & Co., Inc.
|
22,563 | $2,899,345 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
13,514 | $2,562,524 | |
| 5 | AMGN |
Amgen Inc
|
6,044 | $2,188,653 | |
| 6 | NVO |
Novo Nordisk A S
|
14,630 | $701,362 | |
| 7 | JNJ |
Johnson & Johnson
|
2,602 | $660,829 | |
| 8 | BIIB |
Biogen Inc.
|
1,248 | $269,642 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,562,524 | 13,514 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,165,278 | 10,979 | Shares | Sole | 2026-04-30 | |
| No filing history on record for this holder in this stock. | ||||||